Prevention by leucine of hypoglycin-B induced teratogenesis in the rat.
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000596:Amino Acids / Q000037:antagonists & inhibitors*; D000650:Amnion / Q000601:surgery; D000818:Animals; D000831:Animals, Newborn; D004338:Drug Combinations; D005260:Female; D005313:Fetal Death / Q000139:chemically induced*; D005865:Gestational Age; D007267:Injections; D007930:Leucine / Q000627:therapeutic use*; D008297:Male; D010710:Phosphates / Q000008:administration & dosage; D011247:Pregnancy; D051381:Rats; D012256:Riboflavin / Q000008:administration & dosage
D000596:Amino Acids; D004338:Drug Combinations; D010710:Phosphates; D007930:Leucine; D012256:Riboflavin